Audit of negative assessments in a breast-screening programme in women who later develop breast cancer-implications for survival

Breast

Volumn 15, Issue 4, 2006, Pages 503-509

  Allgood, P C ^a   Duffy, S W ^a   Warren, R ^b   Hunnam, G ^c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c NONE

Author keywords

Breast cancer; Core biopsy; Fatality; Guidelines; Mortality; Screening

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; BREAST CANCER; BREAST TUMOR; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER SIZE; CANCER SURVIVAL; CAUSE OF DEATH; CONTROLLED STUDY; FALSE NEGATIVE RESULT; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASS SCREENING; MEDICAL AUDIT; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TUMOR GROWTH; UNITED KINGDOM;

EID: 33746345326     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2005.10.002     Document Type: Article

References (13)

1. Burrell H.C., Sibbering D.M., Wilson A.R., Pinder S.E., Evans A.J., Yeoman L.J., et al. Screening interval breast cancers: mammographic features and prognosis factors. Radiology 199 3 (1996) 811-817
2. Evans A.J., Wilson A.R., Burrell H.C., Ellis I.O., and Pinder S.E. Mammographic features of ductal carcinoma in situ (DCIS) present on previous mammography. Clin Radiol 54 10 (1999) 644-646
3. Burhenne H.J., Burhenne L.W., Goldberg F., Hislop T.G., Worth A.J., Rebbeck P.M., et al. Interval breast cancers in the Screening Mammography Program of British Columbia: analysis and classification. Am J Roentgenol 162 5 (1994) 1067-1071 (discussion 1072-5)
4. Burrell H.C., Evans A., Wilson A.R., and Pinder S.E. False-negative breast screening assessment. What lessons can we learn?. Clin Radiol 56 (2001) 385-388
5. Warren R., Allgood P.C., Hunnam G., Godward S., and Duffy S.W. An audit of breast assessment procedures in women who later develop cancer after a negative result. J Med Screen 11 (2004) 180-186
6. Wilson R., Asbury D., Cooke J., Michell M., and Patnick J. Clinical guidelines for breast cancer screening assessment (2001), NHSBSP, Sheffield
7. Parmar K.B., and Machin D. Survival analysis. A practical approach (1995), Wiley, Chichester
8. Tabar L., Fagerberg C.J., Gad A., et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet i (1985) 829-832
9. Tabar L., Fagerberg G., Duffy S.W., Day N.E., Gad A., and Grontoft O. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin N Am 30 (1992) 187-210
10. Chen H.H., Duffy S.W., Tabar L., and Day N.E. Markov chain models for the progression of breast cancer Part 1: tumour attributes and the preclinical screen-detectable phase. J Epidemiol Biostat 2 (1997) 9-23
11. Chen HH. Mathematical models for progression of breast cancer and evaluation of breast cancer screening. PhD thesis, University of Cambridge, 1995.
12. Duffy S.W., Tabar L., Vitak B., Day N.E., Smith R.A., Chen H.H.T., et al. The relative contributions of screen-detected in situ and invasive carcinomas in reducing mortality from the disease. Eur J Cancer 39 (2003) 1755-1760
13. Cuzick J. A Wilcoxon-type test for trend. Stat Med 4 (1985) 87-90